WordNet

stated explicitly or in detail; "needed a specific amount"
a medicine that has a mitigating effect on a specific disease; "quinine is a specific for malaria"
(sometimes followed by `to'
being or affecting a disease produced by a particular microorganism or condition; used also of stains or dyes used in making microscope slides; "quinine is highly specific for malaria"; "a specific remedy"; "a specific stain is one having a specific affinity for particular structural elements"
relating to or distinguishing or constituting a taxonomic species; "specific characters"
smear with blood, as in a hunting initiation rite, where the face of a person is smeared with the blood of the kill
temperament or disposition; "a person of hot blood"
people viewed as members of a group; "we need more young blood in this organization"
the fluid (red in vertebrates) that is pumped through the body by the heart and contains plasma, blood cells, and platelets; "blood carries oxygen and nutrients to the tissues and carries away waste products"; "the ancients believed that blood was the sea
person who makes a gift of property (同)giver, presenter, bestower, conferrer
(medicine) someone who gives blood or tissue or an organ to be used in another person (the host)
the head of an organized crime family (同)father
the introduction of blood or blood plasma into a vein or artery (同)blood_transfusion
the action of pouring a liquid from one vessel to another

PrepTutorEJDIC

daylight-saving time
《名詞の前にのみ用いて》『特定の』,一定の・『明確な』,明白な・(そのものに)『特有の』,独特の《+『to』+『名』》・〈C〉(…の)特効薬《+『for』+『名』》・《複数形で》明細,細部(details)
『血』,『血』液 / 流血(bloodshed);殺人 / 気質,気性,血気,血潮 / 『血統』,血縁(kinship);生まれ,家柄;《the~》王家の血統 / (人種・出身国の)系 / 〈人〉‘に'初めての経験をさせる / 〈猟犬〉‘に'初めて獲物を血を味わわせる
寄付者,寄贈者 / (移植用の組織・器官の)提供者,献血者
《Don》ドン(Sirに当たるスペイン語で男性の洗礼名の前につける) / 〈C〉スペイン貴族(紳士) / 〈C〉(オックスフォード・ケンブリッジ両大学の)学監,指導教授 / 〈C〉《英》大学教師
〈衣服〉‘を'着る,〈帽子〉‘を'かぶる[do onの短縮形]
輸血

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 腎同種移植片のC4d染色および抗体媒介性拒絶反応の治療 c4d staining in renal allografts and treatment of antibody mediated rejection
2. 腎移植におけるHLAとABOの感作および脱感作 hla and abo sensitization and desensitization in renal transplantation
3. 腎臓移植における移植片機能不全の危険因子 risk factors for graft failure in kidney transplantation
4. 移植腎機能不全発現後の免疫抑制治療の中止 withdrawal of immunosuppression after renal transplant failure
5. 急性心臓同種移植拒絶反応：診断 acute cardiac allograft rejection diagnosis

Quantitative real-time ARMS-qPCR for mitochondrial DNA enables accurate detection of microchimerism in renal transplant recipients.

Hoerning A, Kalkavan H, Rehme C, Menke J, Worm K, Garritsen HS, Büscher R, Hoyer PF.SourceDepartment of Pediatrics II, Children's Hospital, University of Duisburg-Essen, Essen, Germany. a.hoerning@gmx.de
Pediatric transplantation.Pediatr Transplant.2011 Dec;15(8):809-18. doi: 10.1111/j.1399-3046.2011.01581.x. Epub 2011 Oct 4.
The presence of microchimerism in peripheral blood of solid organ transplant recipients has been postulated to be beneficial for allograft acceptance. Kinetics of donor cell trafficking and accumulation in pediatric allograft recipients are largely unknown. In this study, we implemented SNPs of the
PMID 21967552

Cellular therapies supplement: the peritoneum as an ectopic site of hematopoiesis following in utero transplantation.

Muench MO, Chen JC, Beyer AI, Fomin ME.SourceBlood Systems Research Institute, San Francisco, California 94118, USA. mmuench@bloodsystems.org
Transfusion.Transfusion.2011 Nov;51 Suppl 4:106S-117S. doi: 10.1111/j.1537-2995.2011.03373.x.
BACKGROUND: In utero transplantation (IUT) has the potential to treat birth defects early before full development of the immune system. Relatively small grafts, which are not matched for major histocompatibility antigens, can be delivered even before onset of disease symptoms. IUT of hematopoietic s
PMID 22074621

Mothers without HLA antibodies before transplantation have a low risk of alloimmunization post-transplantation.

Gatault P, Jollet I, Rabot N, Boulanger MD, Taupin JL, Barbet C, Baron C, Thierry A, Halimi JM, Lebranchu Y, Touchard G, Büchler M.SourceService de Néphrologie-Immunologie Clinique, Hôpital Bretonneau, CHRU Tours, Tours, France.
Tissue antigens.Tissue Antigens.2011 Oct;78(4):241-8. doi: 10.1111/j.1399-0039.2011.01757.x.
Human leukocyte antigen antibodies (HLA Abs) are associated with poor renal graft outcome. We selected 134 first kidney transplant recipients without HLA Ab (LABScreen® Luminex) before transplantation despite previous allogeneic exposure whether through blood transfusion (BT) and/or pregnancy (PR).
PMID 21929572

Characterization of waves of leukocyte recruitment to the lung allograft and the effect of CTLA4-Ig

Taguchi Tsunenori,Inamura Yukio,Honma Kiri,Kimura Daisuke,Miyakoda Mana,Miyazaki Takuro,Tsuchiya Tomoshi,Yamasaki Naoya,Tagawa Tsutomu,Nagayasu Takeshi,Yui Katsuyuki
Acta Medica Nagasakiensia 56(2), 27-34, 2011-08
… We applied cytotoxic T-lymphocyte-associated antigen 4 (CTLA4)-Ig treatment in combination with donor-specific blood transfusion to the transplantation of lung allograft, which was significantly prolonged by the treatment. …
NAID 120003307693

Hemolytic Reaction Due to Graft-Versus-Host (GVH) Antibody Production After Liver Transplantation from Living Donors : Report of Two Cases

KUNIMASA JUN-ICHI,YURUGI KIMIKO,ITO KAZUHIKO,YAMAOKA YOSHIO,UEMOTO SHINJI,TANAKA KOICHI,YOSHIDA HISAHIRO,MARUYA ETSUKO,SAJI HIROH,YOKOYAMA SHIGEKI
Surgery today : the Japanese journal of surgery 28(8), 857-861, 1998-08-01
NAID 10017511969